一个铁调节的信号通路控制着脂肪棕色和癌症白内障
bioRxiv : the preprint server for biology
|August 12, 2025
概括
癌症缓解症涉及白色脂肪组织 (WAT) 的色. 这项研究揭示了铁代谢和甲二硫酸减少酶A (MSRA) 驱动WAT色,为癌症相关代谢障碍提供了新的治疗点.
科学领域:
- 生物化学 生物化学
- 代谢障碍 代谢障碍 代谢障碍
- 在瘤学瘤学.
背景情况:
- ,一种致命的代谢障碍,影响近一半的癌症患者,其特点是白色脂肪组织 (WAT) 色和缩.
- 胰腺管道腺癌 (PDA) 是一种常见的癌症,与缓冲症有关.
研究的目的:
- 为了研究癌症相关的缓解症中WAT棕色化背后的分子机制.
- 为了确定铁代谢和蛋白质氧化中的关键参与者,这些参与卡赫克西亚.
主要方法:
- 使用患者衍生样本和胰腺管腺癌 (PDA) 鼠标模型.
- 在WAT.中分析了铁代谢和蛋白质性氨酸氧化.
- 研究了 metionin sulfoxide 减少酶 A (MSRA) 和蛋白质激酶 A (PKA) 在脂肪色中的作用.
主要成果:
- 确定了铁的流入和蛋白质性氨酸的氧化作为WAT色的关键发起者.
- 证明铁通过促进其多元化和酶活性来激活MSRA.
- 表明MSRA通过在其ATP结合部位附近保存氨酸来维持PKA活性.
- 在PDA小鼠模型中MSRA删除损害了WAT棕色化,减轻了缓解,并改善了生存率.
结论:
- 确立了铁-MSRA-PKA轴作为癌症相关缓解症的关键联系点.
- 这一轴代表了治疗癌症患者缓解症的潜在治疗目标.
更多相关视频
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
1.6K
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
15.3K
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
